Works matching IS 14611457 AND DT 2022 AND VI 25 AND IP 3


Results: 7
    1
    2
    3
    4

    Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial.

    Published in:
    International Journal of Neuropsychopharmacology, 2022, v. 25, n. 3, p. 252, doi. 10.1093/ijnp/pyab074
    By:
    • Mi, Weifeng;
    • Yang, Fude;
    • Li, Huafang;
    • Xu, Xiufeng;
    • Li, Lehua;
    • Tan, Qingrong;
    • Wang, Guoqiang;
    • Zhang, Kerang;
    • Tian, Feng;
    • Luo, Jiong;
    • Xia, Jielai;
    • Yuan, Kai;
    • Lu, Lin;
    • Deng, Jiahui;
    • Tian, Jingwei;
    • Zhang, Hongyan
    Publication type:
    Article
    5

    Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia.

    Published in:
    International Journal of Neuropsychopharmacology, 2022, v. 25, n. 3, p. 238, doi. 10.1093/ijnp/pyab071
    By:
    • Najarian, Dean;
    • Sanga, Panna;
    • Wang, Steven;
    • Lim, Pilar;
    • Singh, Arun;
    • Robertson, Mary Jane;
    • Cohen, Kristin;
    • Schotte, Alain;
    • Milz, Ruth;
    • Venkatasubramanian, Raja;
    • T'Jollyn, Huybrecht;
    • Walling, David P;
    • Galderisi, Silvana;
    • Gopal, Srihari
    Publication type:
    Article
    6
    7